C69 -Malignant neoplasm of eye and adnexa
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C69 – N =1,869
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1995 | 28.6% | 30.6% | 6.1% | 2% | 32.7% | 98 |
1996 | 34.3% | 20% | 5.7% | 3.8% | 36.2% | 105 |
1997 | 46.1% | 13.7% | 3.9% | 7.8% | 28.4% | 102 |
1998 | 38.2% | 24.5% | 10% | 3.6% | 23.6% | 110 |
1999 | 40% | 24% | 11% | 1% | 24% | 100 |
2000 | 36.2% | 24.1% | 12.1% | 4.3% | 23.3% | 116 |
2001 | 33.3% | 17.9% | 16.7% | 8.3% | 23.8% | 84 |
2002 | 30% | 21.4% | 10% | 7.1% | 31.4% | 70 |
2003 | 27.4% | 21.2% | 17.7% | 8.8% | 24.8% | 113 |
2004 | 21.3% | 22.7% | 17.3% | 5.3% | 33.3% | 75 |
2005 | 22.2% | 26.7% | 11.1% | 2.2% | 37.8% | 90 |
2006 | 25.2% | 30.1% | 8.7% | 4.9% | 31.1% | 103 |
2007 | 14.3% | 28.6% | 10.5% | 3.8% | 42.9% | 105 |
2008 | 20.5% | 37.2% | 11.5% | 3.8% | 26.9% | 78 |
2009 | 24.7% | 34% | 11.3% | 3.1% | 26.8% | 97 |
2010 | 30.5% | 29.5% | 15.2% | 3.8% | 21% | 105 |
2011 | 17.4% | 39.1% | 5.4% | 4.3% | 33.7% | 92 |
2012 | 18.3% | 32.4% | 5.6% | 2.8% | 40.8% | 71 |
2013 | 14.6% | 37.1% | 9% | 4.5% | 34.8% | 89 |
2014 | 16.7% | 36.4% | 18.2% | 6.1% | 22.7% | 66 |